温州制药首富李革，抛售资产。 10月26日，其掌舵的药明康德公告称，拟以28亿元的价格，出售康德弘翼和津石医药全部股权。 标的体量不大，1至9月，两家子公司合计贡献11.6亿元收入、0.9亿元利润，分别占药明康德总盘子的3.5%和0.7%。 “占比不大，且不是主业，出售或许比自己经营更有增益。” 有业内人士向《21CBR》记者解释，药明康德主业增长，两家标的所在的临床CRO业务略显疲软。 ...
Source Link温州制药首富李革，抛售资产。 10月26日，其掌舵的药明康德公告称，拟以28亿元的价格，出售康德弘翼和津石医药全部股权。 标的体量不大，1至9月，两家子公司合计贡献11.6亿元收入、0.9亿元利润，分别占药明康德总盘子的3.5%和0.7%。 “占比不大，且不是主业，出售或许比自己经营更有增益。” 有业内人士向《21CBR》记者解释，药明康德主业增长，两家标的所在的临床CRO业务略显疲软。 ...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.